Akanocure COVID-19 Treatment Strategy (IMAGE)
Caption
Akanocure Pharmaceuticals Inc., a Purdue University-affiliated startup, is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.
Credit
Chris Adam/Purdue University
Usage Restrictions
None
License
Licensed content